Patents
Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445)
10/2002
10/24/2002WO2002084284A2 Diagnosis and treatment of cancer:ii
10/24/2002WO2002083686A2 Processes for large scale production of tetrapyrroles
10/24/2002WO2002083097A2 Drug delivery system for hydrophobic drugs
10/24/2002WO2002083067A2 Prodrugs via acylation with cinnamate
10/24/2002WO2002083030A2 Bifunctional energy-reversible acyl-compositions
10/24/2002WO2002062386A3 Photodynamic therapy of occult choroidal neovascularization linked to age-related macular degeneration
10/24/2002WO2002032397A9 Electroprocessing in drug delivery and cell encapsulation
10/24/2002US20020156117 Receptor-avid exogenous optical contrast and therapeutic agents
10/24/2002US20020156062 Microaggregates of micelles containing phospholipids and a photosensitizer, and the phospholipids are capable of forming a lipid bilayer
10/24/2002US20020155470 Intercalation compound for use in the diagnosis and detection of genetic disorders
10/24/2002US20020155285 Bio-wave card and sticky piece
10/24/2002US20020155099 Transfer of molecules into the cytosol of cells
10/24/2002US20020155098 Methods for treating the inflammatory component of a brain disorder
10/24/2002US20020155089 Drug delivery systems for photodynamic therapy
10/24/2002CA2444264A1 Prodrugs via acylation with cinnamate
10/24/2002CA2444262A1 Bifunctional energy-reversible acyl-compositions
10/24/2002CA2435488A1 Processes for large scale production of tetrapyrroles
10/23/2002EP1250339A1 Porphyrins and related compounds
10/23/2002EP1250333A1 Dendrimer precursor dyes for imaging
10/23/2002EP1250095A1 Versatile hydrophilic dyes
10/23/2002EP1250094A1 Tunable indocyanine dyes for biomedical applications
10/23/2002EP1250093A1 Novel indocyanine dyes
10/23/2002EP1250092A1 Novel dyes
10/23/2002EP0843547B1 Methods of making liposomes containing hydro-monobenzoporphyrin photosensitizers
10/23/2002CN1375333A Biopreparation for treating hepatosis prepared in micro alternate bioelectric field and its prepn.
10/23/2002CA2381875A1 Multioligoanilinated fullerenes
10/22/2002US6469052 Compounds for the photodecontamination of pathogens in blood
10/22/2002CA2218477C Rna photocleavage using texaphyrins
10/17/2002WO2002082044A2 Method of imaging cell death in vivo
10/17/2002WO2002081028A2 Cytoprotection by phosphotyrosine
10/17/2002WO2002080945A2 Methods for treating the inflammatory component of a brain disorder
10/17/2002WO2002080922A1 Method and composition for topical treatment of viral lesions
10/17/2002US20020151792 Method for ultrasound triggered drug delivery using hollow microbubbles with controlled fragility
10/17/2002US20020150632 Psychonutracological method for craving reduction in humans
10/17/2002US20020150560 Treatment of Il-10 deficiencies
10/17/2002US20020150539 Ultrasound imaging and treatment
10/17/2002DE10117834A1 Zytoprotektion durch Phosphotyrosin Cytoprotection by phosphotyrosine
10/17/2002CA2442313A1 Methods for treating the inflammatory component of a brain disorder
10/16/2002EP0637976B2 Medicament for disinfection of the oral cavity
10/10/2002WO2002078694A1 Photosensitiser and method for production thereof
10/10/2002WO2002078638A2 Morpholino imaging and therapy
10/10/2002WO2002030472A3 Compositions for release of radiosensitizers, and methods of making and using the same
10/09/2002EP1246826A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
10/09/2002EP1246648A2 Dendrimer-photosensitizer complexes for medical applications
10/08/2002US6462192 Such as meso-formyl porphyrins, meso-acrylate porphyrins, purpurins and benzochlorins. in particular, tin ethyl etiopurpurin (snet2) and the intermediates necessary for its production without chromatography
10/08/2002US6462070 Photosensitizer conjugates for pathogen targeting
10/08/2002US6461586 Method of magnetic resonance focused surgical and therapeutic ultrasound
10/03/2002WO2002076935A1 Novel a-lipoic acid derivative and use thereof
10/03/2002WO2002076508A1 Methods for delivering nucleic acid molecules into cells and assessment thereof
10/03/2002WO2002076453A1 Methods and compositions for photo-cross linking photoactive compounds to target tissue
10/03/2002WO2002055027A3 Placebo effect and relaxation response
10/03/2002US20020143066 Perylenequinones for use as photosensitizers and sonosensitizers
10/03/2002US20020141993 Apoptosis; anticancer agents
10/03/2002US20020139938 Sensitization of cells with porphyrins, then exposing to radiation and grafting; photodynamic therapy
10/02/2002EP0853628B1 Photolabile 8-substituted cyclic nucleotide esters, methods of preparing them and their use
10/02/2002CN1372467A Improved topical medicaments and methods for photodynamic treatment of disease
10/01/2002CA2068632C Nanocrystalline magnetic iron oxide particles, processes for their preparation and their use in medical diagnostics and therapy
09/2002
09/26/2002WO2002074332A2 Method to enhance the immunogenicity of an antigen
09/26/2002WO2002049635A3 Use of 5-aminolevulinic acid for the prophylaxis of restenosis
09/26/2002WO2002038191A3 Method of inactivating microorganisms in a fluid using ultraviolet radiation
09/26/2002WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation
09/26/2002WO2001090159B1 Compositions and methods for delivery of a molecule into a cell
09/26/2002US20020137924 Such as meso-formyl porphyrins, meso-acrylate porphyrins, purpurins and benzochlorins. In particular, tin ethyl etiopurpurin (SnET2) and the intermediates necessary for its production without chromatography
09/26/2002US20020137901 Synthesis, and photodynamic therapy-mediated anti-cancer, and other uses of chlorin e6-transferrin
09/26/2002US20020137799 Sensitizing tumor cells with terpene such as perillyl alcohol
09/26/2002US20020137735 Therapy of auto-immune disease by a photochemotherapeutical method
09/26/2002US20020137731 Killing cancer cells with vitamin D3 analog ILEX 23-7553 of given structure and ionizing radiation
09/26/2002US20020136729 Combined physical and immunotherapy for cancer
09/26/2002DE10108798A1 Verfahren und Vorrichtung zur ultraschallgestützten transmembranen Medikamentenapplikation in vivo Method and apparatus for ultrasound-guided transmembrane drug delivery in vivo
09/25/2002EP1243278A2 Method of increasing the concentration of nitric oxide in blood
09/25/2002CN1371291A Method and formula for tumor remission and suppression of cancer
09/25/2002CN1371286A Use of cyclooxygenase-2 inhibitor matrix metallappoteinase inhibitor antineoplastic agent and optionally radiation as combination treatment of neoplasia
09/24/2002US6455555 Photosensitizing dye that is a quinolinium- or thiazolium-methine dye
09/19/2002WO2002072143A1 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives
09/19/2002WO2002000870A9 Method for transfecting cells using a magnetic field
09/19/2002US20020133220 Stent for neutron capture therapy and method of manufacture therefor
09/19/2002US20020132771 Binding agent that specifically binds to both soluble and tumor-bound tumor- associated MUC-1 and that is effective in therapeutically treating a mammal having a tumor that expresses a tumor- associated MUC-1.
09/19/2002CA2440319A1 Tumor radiosensitization and/or chemopotentiation using isocoumarin derivatives
09/17/2002US6452037 Carbonylated, oligoanilinated derivatives; antitumor agents; photosensitizers transforming molecular oxygen into singlet oxygen; bioavailable
09/17/2002US6451328 Free radical scavenger for skin; aging resistance; cancer prevention; cosmetics; electropositivity, electronegativity
09/12/2002WO2002069990A1 Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt
09/12/2002WO2002069892A2 METHOD FOR PROTECTING CELLS AND TISSUES FROM IONIZING RADIATION TOXICITY WITH α, β UNSATURATED ARYL SULFONES
09/12/2002WO2002069876A1 Method for treatment of neurodegenerations
09/12/2002WO2002017925A8 Non-symmetric tripyrrannes in the synthesis of novel macrocycles
09/12/2002WO2001040232A9 Chlorophyll and bacteriochlorophyll esters, and their preparation
09/12/2002WO2001015694A9 Extended duration light activated cancer therapy
09/12/2002US20020128695 Apparatus and method for high energy photodynamic therapy of acne vulgaris and seborrhea
09/12/2002US20020128303 Injection with a photodynamic compound having tumor selective uptake which is activated at a particular light frequency; injection with a xanthenone-4-acetic acid or salt; exposing the tumor to light at the activation frequency
09/12/2002US20020128220 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state
09/12/2002US20020127714 Detecting gene expression inhibitor for use in treatment of cancer; obtain nucleotide sequence of allele, incubate with gene expression inhibitor, monitor reduction in gene expression
09/12/2002US20020127230 Transcutaneous photodynamic therapy ("PDT") of a target tissue
09/12/2002US20020127224 Use of photoluminescent nanoparticles for photodynamic therapy
09/12/2002CA2439811A1 Method of treating tumor and consignment system of proliferating and processing activated lymphocytes to be used in parallel to pdt
09/11/2002EP1238666A2 Use of xanthenone-4-acetic acid in the manufacture of a medicament in the treatment of hyperproliferative disorders
09/11/2002EP1238016A1 Substituted phthalocyanines and their precursors
09/11/2002EP1166291A4 Heating of magnetic material by hysteresis effects
09/11/2002EP1001811B1 Nanoscale particles having an iron oxide-containing core enveloped by at least two shells
09/10/2002US6448255 Imidazo-isoquinolin-5-one derivatives, pyrimido-isoquinolin-6-one derivatives and imidazo-naphthyridin-5-one derivatives
09/06/2002WO2002068000A2 Polymeric imagable brachytherapy seed
09/06/2002WO2002067998A2 Devices and methods for the treatment of cancer
1 ... 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 ... 95